Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MI › Lansing › NPI 1801800719

Legacy Physician Group, P.C.

Legacy Physician Group, P.C. was paid $444K by Medicaid between Jul 2020 and Dec 2024, across 26 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 25% of everything it billed.

33Billing provider infoLEGACY PHYSICIAN GROUP, P.C.
LANSING, MI 48912
33aNPI1801800719assigned 07/28/2006
33bProvider typeSpecialist
28Total paid$444K
24GClaims12,560
24DCodes billed26
24AFirst – last monthJul 2020 – Dec 2024
Compared with peers

Next to other Specialist providers in Michigan

Rank by total paid#52 of 181
Median peer was paid$94K
This provider vs. median4.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$20K$40K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2020480$18K
20215,063$180K
20223,851$132K
20231,994$64K
2024incomplete1,172$50K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 25% 1,612 1,468 $111K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 25% 1,809 1,806 $111K
99204 Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 16% 778 773 $70K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 14% 1,895 1,732 $60K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring 5.4% 58 58 $24K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 4.5% 406 390 $20K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 2.3% 94 93 $10K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 1.5% 182 177 $7K
99215 Doctor's office visit, returning patient (complex)Prolong outpt/office vis 1.4% 74 71 $6K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1.3% 84 84 $6K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 15 15 $4K
87634 <1% 75 75 $3K
14 more codes
99001 <1% 243 $3K
99000 <1% 340 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 178 $2K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 89 $1K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 117 $1K
81002 <1% 314 $767.16
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) <1% 18 $585.84
36415 Collection of venous blood by venipuncture <1% 14 $49.63
85018 <1% 14 $22.07
85014 <1% 14 $22.06
99072 0% 3,195 $0.00
99051 0% 878 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 0% 13 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 51 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialFEDEWA, SUSAN (PRESIDENT)